相关实验视频
Updated: Jan 14, 2026

09:28
A Method of Nodose Ganglia Injection in Sprague-Dawley Rat
Published on: November 25, 2014
19.8K
探索阿米特里普提林在调节反射敏感性的作用
Mehdi Modiri1, Reyhaneh Shoorgashti2, Farnaz Haji Fattahi2
1Faculty of Dentistry, Dental Branch, Islamic Azad University of Medical Sciences, Tehran, Iran.
Iranian journal of pharmaceutical research : IJPR
|October 27, 2025
概括
局部使用的阿米特利普提林有效地降低了吐反射强度,与利多卡因相美,为牙科患者提供了新的选择. 这项研究强调了阿米特利普提林作为一种可行的替代方案来管理临床环境中的吐反射.
科学领域:
- 牙科 牙科是指牙科的专业.
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 吐反射是一种关键的呼吸道防御机制.
- 它对多达44%的患者的牙科护理可获得性产生重大影响.
- 严重的吐反射会导致避免必要的牙科治疗.
研究的目的:
- 评估局部阿米特里普提林在减轻反射强度方面的疗效.
- 为了比较阿米特利普提林与利多卡因的效果,这是一种标准治疗.
- 用Gag触发点指数 (GTPI) 来测量吐反射的减少.
主要方法:
- 一个随机的单盲临床试验,涉及48名具有高GTPI得分的参与者.
- 参与者被分为两个组:阿米特利普提林喉 (15毫克/毫升) 和利多卡因喷雾 (10%).
- 干预后测量了GTPI,以及患者报告的味道和气味满意度.
主要成果:
- 亚美和利多卡因都显著降低了吐反射强度 (P < 0.001).
- 阿米特利普提林组的GTPI变化从4.04到1.29; 利多卡因组从4.46到2.42.
- 两组之间在反射减少或感官知觉方面没有发现显著差异.
结论:
- 局部使用的阿米特利普提林 (amitriptyline) 是利多卡因 (lidocaine) 的一种潜在替代品,用于控制吐反射.
- 它特别适合患者对利多卡因不耐受.
- 需要进一步的研究来确定长期的安全性和阐明药理效应.
相关概念视频
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
871
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
871
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
1.4K
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
1.4K
Sedatives and Hypnotics Drugs: Miscellaneous Agents
502
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
502
Cholinergic Antagonists: Therapeutic Uses
1.3K
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
1.3K
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
4.5K
Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
4.5K
Cholinergic Antagonists: Pharmacological Actions
1.6K
Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
1.6K

